M Hentzien
Overview
Explore the profile of M Hentzien including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
73
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Givry F, Lebargy F, Lebrun D, Bonnet M, Ruellan A, Hentzien M, et al.
J Antimicrob Chemother
. 2025 Feb;
PMID: 39989446
Background: Well-established side effects of trimethoprim/sulfamethoxazole include cutaneous and liver toxicity, hypersensitivity syndrome and blood dyscrasias. Trimethoprim/sulfamethoxazole has also been associated with severe lung toxicity (LT) but reports are scarce....
2.
Weber M, Duran Ramirez J, Hentzien M, Cavassini M, Bernasconi E, Hofmann E, et al.
Clin Infect Dis
. 2024 Jan;
79(1):177-188.
PMID: 38214897
Background: Advancements in access to antiretroviral therapy (ART) and human immunodeficiency virus (HIV) care have led to a decline in AIDS-related deaths among people with HIV (PWH) in Switzerland. However,...
3.
Hureaux A, Bermejo M, Suret P, Bonnet M, Nguyen Y, Hentzien M, et al.
Eur J Clin Microbiol Infect Dis
. 2023 Nov;
43(2):379-381.
PMID: 37996727
We investigate spontaneous reports of IIH related to fluoroquinolones recorded in the French national pharmacovigilance database in order to detect a possible pharmacovigilance signal. The association between IIH risk and...
4.
Yaici L, Gatouillat G, Andreoletti L, Nguyen Y, Hentzien M, Gordien E, et al.
Clin Res Hepatol Gastroenterol
. 2023 May;
47(7):102148.
PMID: 37244588
As the loss of HBsAg during treatment of chronic hepatitis delta (CHD) is mandatory for definitive clearance and durable response, the optimal target of therapy should be complete response (CR),...
5.
6.
Dupont M, Carlier C, Gower-Rousseau C, Barbier-Lider P, Botsen D, Brasseur M, et al.
BMC Cancer
. 2022 Nov;
22(1):1219.
PMID: 36434607
Background: Previous studies have observed an increased incidence of Cetuximab-induced hypersensitivity infusion reactions (CI-IRs) in the southeastern states of the USA. Tick's bites were suspected of generating cross-reactions between cetuximab...
7.
Chung M, Andreoletti L, Nguyen Y, Soize S, Bani-Sadr F, Hentzien M
J Neurovirol
. 2022 Oct;
28(4-6):619-621.
PMID: 36194360
We report an acute Coxsackievirus B3 (CVB3)-induced meningo-cerebellitis in an immunocompetent adult patient. CVB3 has a global distribution and is the most common Enteroviruses cause of myocarditis and sudden cardiac...
8.
Favarel-Garrigues M, Cadiot G, Bermejo M, Boulagnon-Rombi C, Bani-Sadr F, Hentzien M
Clin Res Hepatol Gastroenterol
. 2022 Jul;
46(9):101989.
PMID: 35792238
No abstract available.
9.
Le Guillou A, Cabie A, Delpierre C, Pugliese P, Jacomet C, Hentzien M, et al.
Public Health
. 2021 Jun;
196:129-134.
PMID: 34192605
Objectives: As trends in new HIV diagnoses represent a measure of the HIV epidemic, we conducted a 6-year longitudinal study to evaluate the change in rates of new HIV diagnosis,...
10.
Hentzien M, Guihot A, de Maindreville D, Tabary T, Brodard V, Vieillard V, et al.
J Neurovirol
. 2020 May;
26(4):607-610.
PMID: 32458280
In HIV patients, HCV co-infection has been associated with an increased risk of progressive multifocal leukoencephalopathy (PML). Furthermore, PML has also been described in patients with cirrhosis, whether related to...